Monthly Archives: May 2014

EMA data sharing policy could put transparency at risk

Hundreds of you got involved last year when the European Medicine Agency (EMA) opened a consultation on its draft clinical trial data sharing policy. Back then, we welcomed the EMA’s proposals which would have seen clinical study reports published proactively and openly. We now hear that an updated draft of the policy puts this at […]

30th May 2014|

YODA Draft Data Release Policy open for comment

The Yale Open Data Access (YODA) Project is inviting comment on their proposed policy to make available clinical trial data from Johnson and Johnson. Read the message from Harlan Krumholz below and add your comment on their website.
In January the Yale Open Data Access (YODA) Project signed an agreement with Janssen Pharmaceutics of Johnson and Johnson to […]

30th May 2014|

Urgent: Write Canadian MPs to bring Clinical Trial Transparency to Canada

Canadians: We have just heard that we have a chance to improve clinical trial transparency in Canada. Bill C-17 or “Vanessa’s Law” is being considered this Tuesday and there’s a chance to get clinical trial transparency measures added to it.

We urgently need you to write to the MPs on the Standing Committee on Health to tell […]

23rd May 2014|

AllTrials video – make clinical trials count

It’s time all clinical trial results are reported. Watch this video and change something.

Results from around half of clinical trials have never been published. Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and […]

19th May 2014|

New study shows half of chronic pain research remains unreported

Results from more than half of clinical trials for common chronic pain disorders are not readily available on global registries, according to a new paper in the journal PAIN . The survey included 15 major registries accessible through the World Health Organisation’s International Clinical Trials Registry Platform. Of the 447 unique trials identified, only 46% […]

15th May 2014|

100,000 for AllTrials by International Clinical Trials Day

International Clinical Trials Day is Tuesday 20th May 2014 and we cannot afford to lose momentum for AllTrials. Help us get to 100,000 signatures on the AllTrials petition. Here’s what you can do today:

Share the petition. Make it your goal to get 10 new signatures. Email it to your friends, family and co-workers, share it on […]

14th May 2014|

Share the AllTrials Twitpic

Help us reach 100,000 signatures on the AllTrials petition – share this image on Facebook and Twitter.

Click on the image to open a full-sized version.

“Results from half of all clinical trials remain hidden.
Contributions from hundreds of thousands of patients in those trials remain unused and unusable.
Sign the AllTrials petition to make them count.
www.AllTrials.net”
 

Or press retweet below:
Results […]

14th May 2014|

Boehringer Ingelheim to register clinical trials back to 1998

Pharmaceutical company Boehringer Ingelheim has pledged to register all clinical trials dating back to 1998 on the publicly accessible register ClinicalTrials.gov.

In a press release yesterday Boehringer announced its strategy to fulfil commitments it made in 2013. A new website will facilitate access to anonymised individual patient data for researchers who have submitted their analysis plans to an […]

13th May 2014|

Transparency is “critical” says Canadian MP

In a debate in the Canadian House of Commons, Conservative Member of Parliament Terence Yong called clinical trial transparency “critical” and stated that he would like to see the registration and reporting of clinical trials added to his bill to amend the Food and Drug Act.

The comments were made on 28th March 2014 during the […]

12th May 2014|

Swedish Medical Association joins AllTrials

Sveriges läkarförbund, the Swedish Medical Association (SMA), has joined the AllTrials campaign. The Association represents 45,000 physicians in Sweden.

In a statement the SMA said
The SMA finds it very important that results from clinical trials and other clinical research studies are made available regardless of where in the world the studies take place. We welcome stricter regulation […]

9th May 2014|